POST Online Media Lite Edition


PT Kalbe Farma in Indonesia to give Remdesivir for coronavirus treatment

Christian Fernsby |
Indonesian pharmaceutical company PT Kalbe Farma is collaborating with India's PT Amarox Pharma Global to launch antiviral drug Covifor (Remdesivir) for coronavirus treatment in the Southeast Asian country.

Article continues below

Topics: INDONESIA   

Amarox Pharma Global is a subsidiary of Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs. It is the first company to receive the Emergency Use Authorization approval for Remdesivir from the Indonesian Food and Drug Authority.

“The drugs are ready to be distributed across the country,” said Vidjongtius, president director of Kalbe Farma, during a virtual press conference on Thursday.

The authorization is for treatment of coronavirus in adults and adolescents (age 12 and older with body weight at least 40 kg) hospitalized with severe disease.

Covifor will be distributed to referral hospitals that treat virus patients as it is meant for emergency use only.

The price will be set at 3 million Rupiah ($202) per vial (small container to store liquid medication), and could be even cheaper if the volume of imports is increased.

Sundeep Sur, the country manager of Amarox Pharma, said the company would prepare supplies as per Indonesian needs.

"Currently the minimum supply to Indonesia is around 200,000 to 300,000 vials, and it could be increased," he said.

What to read next

China's ICBC bank offers $500 million in loan to Indonesian Eximbank
Telstra and Telkom Indonesia in joint venture
China's CCB bank launches Indonesia brand